Book icon with persian name of Pubnito
  • Mağaza
  • Kütüphane
  • Sepetiniz


    Tüm nesneler:0

    Sepeti Görüntüle

    Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

    Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

    Atta-ur-Rahman

    "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics - Prospects for therapeutic targeting of microRNAs in brain tumors - Breast cancer vaccines: current status and future approach - Desmocollin-3 and cancer - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53 - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials" "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics - Prospects for therapeutic targeting of microRNAs in brain tumors - Breast cancer vaccines: current status and future approach - Desmocollin-3 and cancer - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53 - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials"

    kitap formatı

    kitap lisansı

    $ 79.00

    Yorumlar

    Derecelendirme Anlık Görüntüsü

    İncelemeleri filtrelemek için aşağıdan bir satır seçin.

    0

    0

    0

    0

    0

    0

    Genel

    Ortalama Müşteri Puanları

    Bu Kitap için İnceleme

    Düşüncelerinizi diğer okuyucularla paylaşın

    Daha Fazla Bilgi

    description_of_book

    "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for de

    Ek Bilgi

    SATICI

    Yayın tarihi

    2021 Dec 03

    Yazarlar
    Atta-ur-Rahman

    ISBN

    9781681089317

    Yazarlar Hakkında

    Atta-ur-Rahman
    Atta-ur-Rahman
    Atta-ur-Rahman

    İçindekiler

    logo

    Türkçe

    PUBNiTO tarafından desteklenmektedir | © 2024 Notion Wave A.Ş.